ASCO 2022 Conference Coverage


 

ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder Preservation for Patients Whose Tumors Harbor Deleterious DNA Damage Response Gene Alterations (Alliance A031701)

131 views
June 8, 2022
Comments 0
Login to view comments. Click here to Login